openPR Logo
Press release

Antifungal Drugs Market Research Report Focusing on Leading Fortune Companies Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc, Novartis International AG, Abbott Laboratories & Many Others

03-21-2019 01:47 PM CET | Health & Medicine

Press release from: Allied Market Research

Antifungal Drugs Market Research Report Focusing on Leading

Global Antifungal Drugs Market is expected to rise from $13,719 million in 2016 to $17,718 million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period, 2017 - 2023. The antifungal drugs detect and eliminate fungal pathogens providing minimal side effect to the body. The fungal infection in the body is caused due to unhygienic and unclean environments wherein fungal agent thrive. These agents multiply by spreading spores that subsequently lead to infection on skin (superficial) or when inhaled (systemic)-fungal infections. The fungal infection leads to candidiasis, fungal pneumonia, mucormycosis, and other diseases. These infections are mostly non-lethal, but can result in death in rare cases.

Get PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2370

Antifungal drugs are medications that selectively eliminate fungal infections from the host. These fungal agents multiply by spreading spores that subsequently lead to infection on skin, hairs, vagina, and other body parts. The fungal infection causes candidiasis, fungal pneumonia, mucormycosis, and other diseases. The antifungal drugs market is continuously growing and evolving owing to robust developmental efforts made by researchers and market players in the field.

The growth in prevalence of fungal infection, rise in awareness levels pertaining to myriad fungal infections, and increase in demands of generic drugs are the major factors that drive the market growth. However, patent expiration of branded therapeutics and presence of counterfeit drugs restrain the growth of the antifungal drugs market. In addition, increase in R&D expenditure coupled with funding from the public & private sector is expected to provide lucrative growth opportunities to the antifungal drugs market.

The systemic antifungals segment is anticipated to maintain its dominance during the forecast period, accounting for about fifth-sevenths share of the global antifungal drugs market in 2016. This is due to the high usage of drugs such as azole for all the fungal indications and these also offer broad spectrum activity and improved safety levels. In addition, rise in prevalence of most commonly occurring systematic fungal infection such as candidiasis supplements the market growth. However, the superficial antifungals are expected to grow rapidly throughout the forecast period. This is because of the growth in incidence of hospital-acquired infections and increase in life expectancy among people.

The dermatophytosis indication is expected to register the highest CAGR of 4.1% throughout the forecast period. This is because of high incidences of skin infections in both children and adults. Candidiasis indication generated the highest revenue in 2016, accounting for about one-third of the total share in 2016, and is anticipated to maintain this trend from 2017 to 2023.

Get More Details @ https://www.alliedmarketresearch.com/connect-to-analyst/2370

In 2016, Asia-Pacific and LAMEA collectively accounted for about three-eighths share of the market and is expected to continue this trend throughout the forecast period. Increase in awareness regarding antifungal drugs, availability of these drugs specifically in China, India, and the other developing economies, and growth in awareness regarding the fungal diseases drive the market. Moreover, the massive target population and growth in economy catering to the establishment of healthcare facilities boost the market.

The report provides a comprehensive analysis of the key players operating in the global antifungal drugs market such as

• Pfizer Inc.,
• Sanofi S.A.,
• Gilead Sciences, Inc.,
• Merck & Co., Inc.,
• Novartis International AG,
• Abbott Laboratories,
• Bayer AG,
• Scynexis Inc.,
• Enzon Pharmaceuticals, Inc., and
• GlaxoSmithKline Plc.

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Increasing prevalence of fungal infection
3.6.1.2. Rising awareness levels pertaining to myriad fungal infections
3.6.1.3. Favorable government funds to combat the antifungal diseases
3.6.2. Restraints
3.6.2.1. Growing population with antifungal drug resistance
3.6.2.2. Presence of counterfeit drugs and side effects of antifungal drugs
3.6.3. Opportunities
3.6.3.1. Patent expirations and increasing funding from public & private organizations

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/antifungal-drugs-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antifungal Drugs Market Research Report Focusing on Leading Fortune Companies Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc, Novartis International AG, Abbott Laboratories & Many Others here

News-ID: 1665920 • Views: 327

More Releases from Allied Market Research

Treasury and Risk Management Market Insights 2020: Top Factors That Are Leading …
The Treasury and Risk Management Market report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Management of large quantity of data in a centralized manner by
Service Integration and Management Market 2020: Technical Signs Point Rapid Grow …
The Objective of the “Global Service Integration and Management Market ” report is to depict the trends and upcoming for the Service Integration and Management Market industry over the forecast years. Service Integration and Management Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2027 mulling over 2019 as the base year of the
Wealth Management Platform Market 2020 Technical Signs Point Rapid Growth In Com …
The Objective of the “Global Wealth Management Platform Market ” report is to depict the trends and upcoming for the Wealth Management Platform Market industry over the forecast years. Wealth Management Platform Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2027 mulling over 2019 as the base year of the market study. Attentiveness
Deep Learning Market Size 2020: Innovation and Product Optimization With Dominat …
Allied Market Research published a new report, titled, " Deep Learning Market " The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Rising need

All 5 Releases


More Releases for Antifungal

Global Antifungal Agents Market Data Survey Report 2025
The Global Antifungal Agents Market was esteemed at USD 10.7 billion out of 2018 and is relied upon to achieve an estimation of USD 12.6 billion by 2025. The expanding occurrence of contagious diseases global is the key contributing variable for the development of the Global Antifungal Agents Market in the coming years. Rising selection of immunosuppressive and antineoplastic specialists, prosthetic gadgets and unions, and wide range anti-infection agents have
Global Antifungal Agents Market Research and Forecast, 2018-2023
The global antifungal agents market size, market trends, research and analysis report by Drug Class (Polyene, Echinocandins, Allylamines, Azole) By dosage type (Powders, Ointments, Drugs, Paste) forecast 2018-2023 According to OMR analysis, the global antifungal agents market is estimated to grow at a moderate rate during the forecast period, 2018-2023. The major factors primarily driving the market includes rising incidence and prevalence of fungal diseases, significant R&D investment, and increasing demand
Antifungal Drugs Market: Global Industry Analysis and Forecast 2016 - 2024
Antifungal drugs medication is done for treating fungal infections with minimal side effects on the body. Basically this fungal infections are organism that feed by breaking down the living tissue these fungi are commonly known as dermatophytes. Dermatophytes can cause infection of the skin, hair and nail as they have a unique ability to utilize the keratin. There are some common fungal infections such as ringworm, athlete’s foot, fungal n
Global Antifungal Agents Market 2018 - Glaxosmithkline, Bayer Healthcare, Novart …
Global Antifungal Agents Market 2018 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Antifungal Agents piece of the overall industry and Growth patterns, concentrating on driving Antifungal Agents industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2025. The major regions present in the continents like United States, Germany, Japan and China and their contribution to global Antifungal Agents market is
Focus on Global Antifungal Market: Industry Analysis & Outlook (2016-2020)
19 Feb 2018 "Global Antifungal Market: Industry Analysis & Outlook (2016-2020)" with coming years Industries Trends, projections of Global Growth, Major key player and Case study, Review, Share, Size, Effect. . . Report Description- '
Global Antifungal Drugs Market Research Report 2017
Report Hive Market Research Released a New Research Report of 116 pages on Title " Global Antifungal Drugs Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Antifungal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented